Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1896 Records) |
| Query Trace: Adenocarcinoma and EGFR[original query] |
|---|
| Prediction of EGFR-TP53 genes co-mutations in patients with lung adenocarcinoma (LUAD) by F-FDG PET/CT radiomics. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 9 . Shuheng Li, Yujing Hu, Congna Tian, Jiusong Luan, Xinchao Zhang, Qiang Wei, Xiaodong Li, Yanzhu Bi |
| Lung microbial and host genomic signatures as predictors of prognosis in early-stage adenocarcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 9 . Jun-Chieh J Tsay, Fares Darawshy, Chan Wang, Benjamin Kwok, Kendrew K Wong, Benjamin G Wu, Imran Sulaiman, Hua Zhou, Bradley Isaacs, Matthias C Kugler, Elizabeth Sanchez, Alexander Bain, Yonghua Li, Rosemary Schluger, Alena Lukovnikova, Destiny Collazo, Yaa Kyeremateng, Ray Pillai, Miao Chang, Qingsheng Li, Rami S Vanguri, Anton S Becker, William H Moore, George Thurston, Terry Gordon, Andre L Moreira, Chandra M Goparaju, Daniel H Sterman, Aristotelis Tsirigos, Huilin Li, Leopoldo N Segal, Harvey I Pa |
| Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA (ctDNA) in Routine Clinical Practice. Oncology 2024 9 1-24. Shaheenah Dawood, Nippun Sandhir, Marwan Akasheh, Maroun El Khoury, Sonia Otsmane, Muath Alnassar, Omalkhair Abulkhair, Fadi Farhat, Steve Ols |
| Clinical and Genetic Characteristics of Early-onset Lung Adenocarcinoma in a Large Chinese Cohort. The Annals of thoracic surgery 2024 9 . Shouzhi Xie, Qikang Hu, Zeyu Wu, Bin Wang, Yu He, Qi Huang, Zhe Zhang, Zhi Yang, Shengrong Wu, Weiyu Yang, Xinhang Hu, Xuyang Yi, Hao He, Cheng Wang, Fenglei Yu, Muyun Pe |
| Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma. Experimental & molecular medicine 2024 9 . Hyondeog Kim, Wonyeop Lee, Youngwook Kim, Sang-Jin Lee, Wonyoung Choi, Geon Kook Lee, Seung-Jin Park, Shinyeong Ju, Seon-Young Kim, Cheolju Lee, Ji-Youn H |
| Outcomes with non-small cell lung cancer and brain-only metastasis. Heliyon 2024 9 10 (17): e37082. Sabine Schmid, Miguel Garcia, Luna Zhan, Sierra Cheng, Khaleeq Khan, Maisha Chowdhury, Amir Sabouhanian, Joshua Herman, Preet Walia, Evan Strom, M Catherine Brown, Devalben Patel, Wei Xu, Frances A Shepherd, Adrian G Sacher, Natasha B Leighl, Penelope A Bradbury, Geoffrey Liu, David Shul |
| EGFR-TKI combined with radiotherapy in 105 patients of lung adenocarcinoma with brain metastasis: a retrospective study of prognostic factors analysis. Oncology research and treatment 2024 9 1-32. Wenjuan Yu, Yuan Xing, Xiao Song, Tian Li, Mi Zha |
| Case report of a patient with stage IV lung adenocarcinoma and uncommon/compound EGFR mutations who responded to afatinib. Respiratory medicine case reports 2024 9 51 102094. Hisanori Hirokawa, Hirokuni Hirata, Hayase Azuma, Kei Sugitate, Sayo Soda, Jun Matsushima, Yasutsugu Fukushi |
| Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space. Translational lung cancer research 2024 9 13 (8): 1862-1876. Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo |
| The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study. Japanese journal of clinical oncology 2024 9 . Tomohiro Miyoshi, Keiju Aokage, Shun-Ichi Watanabe, Hiroyuki Ito, Noriaki Sakakura, Mingyon Mun, Motohiro Yamashita, Yasuhisa Ohde, Tadashi Aoki, Wataru Nishio, Masataka Taguri, Masahiro Tsub |
| The Effect of Intracranial Control After Intracranial Local Therapy on the Prognosis of Patients with Brain Metastasis of Lung Adenocarcinoma. Cancer management and research 2024 8 16 977-988. Minmin Shen, Qiaojing Lin, Xi Zou, Yufan Wu, Zhihong Lin, Linglong Shao, JinSheng Hong, Jinmei Ch |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Comparative genomic and immunopathologic analysis of lung adenocarcinomas with and without cytology-proven malignant pleural effusions. Cancer cytopathology 2024 8 . Cristiana M Pineda, Adnan Majid, Daniel B Costa, Paul A VanderLa |
| Efficacy and Safety of Anlotinib in EGFR-Positive Patients with Advanced Lung Adenocarcinoma Compared with Chemotherapy: A Retrospective Study. Technology in cancer research & treatment 2024 8 23 15330338241279111. Cuihong Cai, Qian Shen, Jingjing Shao, Jingjing Qu, Shuangshuang Zhou, Jianya Zh |
| Effect of TTF-1 expression on progression free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer. Journal of cancer research and clinical oncology 2024 8 150 (8): 394. Mark Uhlenbruch, Stefan Krüg |
| Combination Therapy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel for Metastatic Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Resistance and EGFR Mutations. Cureus 2024 8 16 (8): e67307. Hironori Kobayashi, Ayumu Otsuki, Sadakatsu Ikeda, Kei Nakashima, Yu Oya |
| [Gene mutation characteristics of clinical stage ?A lung adenocarcinoma and their relations with patients' long-term prognosis]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 8 46 (8): 755-763. L Zhang, M W Liu, L Li, S Zhao, L L Wu, Z H Yin, M Li, Y N Gao, N |
| Comprehensive Analysis Reveals Epithelial Growth Factor Receptor as a Potential Diagnostic Biomarker in Glioblastoma Multiforme. Cureus 2024 8 16 (7): e64506. Amna Makawi, Somia A Khalafallah, Israa M Faris, Mohamed Alfa |
| Correction: The Ineffectiveness of Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Lung Adenocarcinoma With Bone Metastasis: A Case Report. Cureus 2024 8 16 (8): c188. Caitlyn H Livingston, Benjamin Harper, Mathew Geor |
| Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations. Cell proliferation 2024 7 e13708. Amanda Huee-Ping Wong, Min En Nga, Chin Yein Chin, Yee Kit Tai, Hung Chew Wong, Ross Soo, Omer An, Henry Yang, Ju Ee Seet, Yaw Chyn Lim, John Kit Chung Tam, Thai Tr |
| Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data. Translational lung cancer research 2024 7 13 (6): 1296-1306. Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu |
| Highly consistency of PIK3CA mutation spectrum between circulating tumor DNA and paired tissue in lung cancer patients. Heliyon 2024 7 10 (13): e34013. Yan Liu, Hui Li, Xiang Li, Tingting Zhang, Yang Zhang, Jing Zhu, Heran Cui, Rixin Li, Ying Che |
| Prognostic Impact of Reactive Oxygen Species Modulator 1 in Surgically Resected Epidermal Growth Factor Receptor-mutant Lung Adenocarcinomas. Oncology 2024 7 . Tae-Woo Kim, Kiyong Na, Junyang Jung, Heejin Lim, Hyewon Seo, Seung Hyeun L |
| Clinical, Imaging, and Pathological-Molecular Characteristics Associated with Stage IA Invasive Lung Adenocarcinoma Recurrence After Sub-lobar Resection. Academic radiology 2024 7 . Xin Fan, Chen Liang, Xueqin Ma, Qi |
| PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression. Genome medicine 2024 7 16 (1): 91. Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn Wei Qian Koh, Choon Kong Yap, Edwin Kok Hao Lim, Jianbin Chen, Yuhua Lim, Jane Jia Hui Lee, Anders Jacobsen Skanderup, Zhenxun Wang, Weiwei Zhai, Nguan Soon Tan, Chandra S Verma, Yvonne Tay, Daniel Shao Weng Tan, Wai Leong T |
| Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis. Frontiers in oncology 2024 7 14 1354854. Xueming Xia, Wei Du, Yan Zhang, Yanying Li, Min Yu, Yongmei L |
| The efficacy of postoperative radiotherapy in resected p?A-N2 EGFR mutant and wild-type lung adenocarcinoma. iScience 2024 7 27 (7): 110219. Yue Zeng, Xing-Xiang Pu, Feng-Jiao He, Chun-Hong Hu, Hong Zhu, Yan Huang, Yu-Rong Peng, Ji-An Zou, Jun-Qi Liu, Sheng-Hao Shi, Yue-Fei Liu, Fang Ma, Chao Deng, Zhen-Hua Qiu, Yan-Long Li, Ying-Zhe Zhang, Kun Huang, Xian-Ling Liu, Fang |
| Correlation of FDG PET/CT, tumor markers and Ki-67 index with EGFR mutation or positive ALK expression in patients with non-small cell lung cancer. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2024 7 . Hui C Wang, Zhi M Wang, Wei D Hu, Xiao Q Liang, Lan L C |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination. International journal of molecular sciences 2024 7 25 (13): . Po-Hsin Lee, Wei-Fan Ou, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Gee-Chen Chang, Tsung-Ying Ya |
- Page last reviewed:Feb 1, 2024
- Content source: